$33.99
0.00 (0%)
ICOS CP (NASDAQ:ICOS.DL)
CAPS Rating:
A biotechnology company, which through Lilly ICOS LLC, markets Cialis (tadalafil) for the treatment of erectile dysfunction. Works to develop potential treatments for other serious unmet medical conditions such as cancer and inflammatory diseases.
- Quote
- Commentary
- Scorecard
- Historical Prices
- Chart
- Stats
- Ratios
- Earnings/Growth Rates
- Statements
- SEC Filings
No players have picked ICOS.DL yet. Tell us why you think ICOS.DL will outperform or underperform the market.
RSS Headlines
Fool UK
